Sign in

CIK 0001754068

  • Non-accelerated filer
  • Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831971007
Phone
+1 650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-16 VAN BEEK JEROEN B Chief Commercial Officer Sale −400 $42.52 $17K 507,630
2021-02-16 Hagen Brett R Chief Accounting Officer Sale −2,750 $41.82 $115K 68,926
2021-02-16 Hagen Brett R Chief Accounting Officer Sale −300 $42.67 $13K 68,626
2021-02-02 Melian Agustin Chief Medical Officer Sale −54,849 $41.19 $2.3M 520,266
2021-02-02 VAN BEEK JEROEN B Chief Commercial Officer Sale −48,910 $41.19 $2.0M 510,730
2021-01-21 Hallal David Chief Executive Officer Grant or award +147,000 2,230,666
2021-01-21 Hallal David Chief Executive Officer Grant or award · Stock Option (Right to Buy) +273,000 273,000
2021-01-19 Atillasoy Ercem Grant or award +28,000 106,500
2021-01-19 Atillasoy Ercem Grant or award · Stock Option (Right to Buy) +52,000 52,000
2021-01-19 Melian Agustin Chief Medical Officer Grant or award +43,750 575,115
2021-01-19 Melian Agustin Chief Medical Officer Grant or award · Stock Option (Right to Buy) +81,250 81,250
2021-01-19 Sinha Vikas Director Grant or award +58,800 865,407
2021-01-19 Sinha Vikas Director Grant or award · Stock Option (Right to Buy) +109,200 109,200
2021-01-19 Hagen Brett R Chief Accounting Officer Grant or award +17,500 71,676
2021-01-19 Hagen Brett R Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +32,500 32,500
2021-01-19 Leen Ann M. Chief Scientific Officer Grant or award +28,000 28,000
2021-01-19 Leen Ann M. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +52,000 52,000
2021-01-19 Miller Edward General Counsel Grant or award +28,000 194,051
2021-01-19 Miller Edward General Counsel Grant or award · Stock Option (Right to Buy) +52,000 52,000
2021-01-19 VAN BEEK JEROEN B Chief Commercial Officer Grant or award +35,000 559,640

Page 25 of 27 · 527 trades